2,6-diallylnaphthalene-1,5-diyl diacetate | 137517-26-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: 2,6-diallylnaphthalene-1,5-diyl diacetate
• 英文别名: [5-Acetyloxy-2,6-bis(prop-2-enyl)naphthalen-1-yl] acetate
• CAS: 137517-26-1
• 化学式: C₂₀H₂₀O₄
• 分子量: 324.376
• InChiKey: FXIQJNVOSYMZPV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.8
• 重原子数：
  24
• 可旋转键数：
  8
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  52.6
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  2,6-diallylnaphthalene-1,5-diyl diacetate 在 palladium on activated charcoal 甲醇 、 甲烷磺酸 、 氢气 、 potassium carbonate 、 乙酰氯 作用下， 以 乙醇 、 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 生成 4,9-Dimethyl-2,7-dipropyl-1,6-dioxapyrene
  参考文献：
  名称：

  Synthesis and properties of substituted 1,6-dioxapyrene donors

  摘要：

  The synthesis of substituted 1,6-dioxapyrenes, 2b-g, from 2,6-dipropyl-1,5-naphthalenediol (7a) or 2,6-dimethyl-1,5-naphthalenediol (7b) is described. Diol 7a was prepared by Claisen allylic rearrangement followed by reduction, and 7b was prepared by Mannich reaction of 1,5-naphthalenediol followed by base-promoted hydrogenolysis. The 1,6-dioxapyrenes can be oxidized to stable cation radicals at +0.2-0.35 V vs SCE and to dications at +0.8-1.20 V. The preparation of some tetracyanoquinodimethane salts and binary cation radical salts of the 1,6-dioxapyrenes is reported.

  DOI：

  10.1021/jo00025a020
• 作为产物：
  描述：

  1,5-二羟基萘 在 十二烷 、 potassium carbonate 、 三乙胺 作用下， 以 四氢呋喃 、 二氯甲烷 、 丙酮 为溶剂， 反应 33.0h， 生成 2,6-diallylnaphthalene-1,5-diyl diacetate
  参考文献：
  名称：

  NOVEL NAPHTHYLENYL COMPOUNDS FOR LONG-ACTING INJECTABLE COMPOSITIONS AND RELATED METHODS

  摘要：

  本发明提供了用于治疗阿片类依赖、酒精依赖、酒精使用障碍或预防需要此类治疗的对象复发至阿片类依赖的化合物。相关的药物组合和方法也在此提供。

  公开号：

  US20200016151A1

文献信息

• NOVEL NAPHTHYLENYL COMPOUNDS FOR LONG-ACTING INJECTABLE COMPOSITIONS AND RELATED METHODS
  申请人：Alkermes Pharma Ireland Limited

  公开号：US20200016151A1

  公开（公告）日：2020-01-16

  The present invention provides compounds useful for the treatment of opioid dependence, alcohol dependence, alcohol use disorder, or the prevention of relapse to opioid dependence in a subject in need thereof. Related pharmaceutical compositions and methods are also provided herein.

  本发明提供了用于治疗阿片类依赖、酒精依赖、酒精使用障碍或预防需要此类治疗的对象复发至阿片类依赖的化合物。相关的药物组合和方法也在此提供。
• 알콕시실릴기 및 활성 에스테르기를 갖는 화합물, 이의 제조방법, 이를 포함하는 조성물 및 용도
  申请人：KOREA INSTITUTE OF INDUSTRIAL TECHNOLOGY 한국생산기술연구원(319999029382) BRN ▼119-82-01008

  公开号：KR20170092468A

  公开（公告）日：2017-08-11

  본 발명은 에폭시 조성물의 경화시에 향상된 저흡습성 및/또는 저유전특성을 나타내지만, 열팽창 특성의 손실을 동반하지 않는 알콕시실릴기 및 활성 에스테르기를 갖는 새로운 화합물, 이의 제조방법, 이를 포함하는 조성물 및 용도에 관한 것이다. 본 발명에 의하면, 화학식 AF 내지 LF의 알콕시실릴기 및 활성 에스테르기를 갖는 새로운 화합물, 이의 제조방법, 이를 포함하는 조성물 및 이의 용도가 개시된다.

  这项发明涉及一种具有改进的低吸湿性和/或低膨胀特性而不伴随热膨胀特性损失的含有醇酰亚基和活性酯基的新化合物的固化物，其制备方法，包含它的组合物以及其用途。根据本发明，提供了一种具有化学式AF至LF的醇酰亚基和活性酯基的新化合物，其制备方法，包含它的组合物以及其用途。
• COMPOUND HAVING ALKOXYSILYL GROUP AND ACTIVE ESTER GROUP, METHOD FOR PREPARING SAME, COMPOSITION COMPRISING SAME, AND USE
  申请人：KOREA INSTITUTE OF INDUSTRIAL TECHNOLOGY

  公开号：US20200165275A1

  公开（公告）日：2020-05-28

  The present invention relates to a novel compound having an alkoxysilyl group and an active ester group, a method for preparing the same, a composition comprising the same, and a use, wherein the novel compound exhibits improved low moisture absorption and/or low dielectric properties when cured as an epoxy composition, but is not accompanied by loss of thermal expansion characteristics. Disclosed are a novel compound of formulae AF to LF having an alkoxysilyl group and an active ester group, and a method for preparing the same, a composition comprising the same, and a use of same.

  本发明涉及一种具有烷氧基硅基团和活性酯基团的新化合物，以及其制备方法、包含该化合物的组合物和用途，其中该新化合物在作为环氧组合物固化时表现出改善的低吸湿性和/或低介电性能，但不伴随热膨胀特性的丧失。公开了具有烷氧基硅基团和活性酯基团的化合物AF至LF的新化合物，以及其制备方法、包含该化合物的组合物和用途。
• Inexpensive and rapid hydrogenation catalyst from CuSO4/CoCl2 — Chemoselective reduction of alkenes and alkynes in the presence of benzyl protecting groups
  作者：Mario Ficker、Søren W. Svenningsen、Thomas Larribeau、Jørn B. Christensen

  DOI：10.1016/j.tetlet.2018.02.026

  日期：2018.3

  The simple reduction of a number of alkenes and alkynes was performed with a typical reaction time of 20 min using a copper-cobalt catalytic system. The reduction did not cleave benzyl protecting groups which are usually vulnerable to catalytic hydrogenation reactions. The catalyst can be prepared in situ by reduction of the inexpensive precursor salts CuSO4 and CoCl2 with NaBH4. Sodium borohydride

  使用铜-钴催化系统，典型的反应时间为20分钟，可以简单地还原许多烯烃和炔烃。还原没有裂解通常易受催化氢化反应影响的苄基保护基。可以通过用NaBH 4还原廉价的前体盐CuSO 4和CoCl 2来原位制备催化剂。硼氢化钠还用作易于处理的氢源，用于催化还原。无需压力，加热或惰性气氛，并且使用萃取程序即可实现纯化/催化剂的去除，从而使该方法既简单又有效。
• Naphthylenyl compounds for long-acting injectable compositions and related methods
  申请人：Alkermes Pharma Ireland Limited

  公开号：US10799496B2

  公开（公告）日：2020-10-13

  The present invention provides compounds useful for the treatment of opioid dependence, alcohol dependence, alcohol use disorder, or the prevention of relapse to opioid dependence in a subject in need thereof. Related pharmaceutical compositions and methods are also provided herein.

  本发明提供的化合物可用于治疗阿片类药物依赖、酒精依赖、酒精使用障碍，或防止有需要的受试者复发阿片类药物依赖。本文还提供了相关的药物组合物和方法。